Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Zhang

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Transplantation Direct|November 28, 2019
Brief Normothermic Machine Perfusion Rejuvenates Discarded Human KidneysAhmer M Hameed, David B Lu, Ellis Patrick, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 1, 2023
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal AntibodiesGary J Schiller, Brea C Lipe, Nizar J Bahlis, et al.
Ejhaem|December 5, 2022
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatmentMuhamed Baljevic, Cristina Gasparetto, Gary J Schiller, et al.
British Journal of Cancer|November 21, 2021
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patientsCristina Gasparetto, Gary J Schiller, Sascha A Tuchman, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Transplantation Direct|November 28, 2019
Brief Normothermic Machine Perfusion Rejuvenates Discarded Human KidneysAhmer M Hameed, David B Lu, Ellis Patrick, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 1, 2023
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal AntibodiesGary J Schiller, Brea C Lipe, Nizar J Bahlis, et al.
Ejhaem|December 5, 2022
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatmentMuhamed Baljevic, Cristina Gasparetto, Gary J Schiller, et al.
British Journal of Cancer|November 21, 2021
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patientsCristina Gasparetto, Gary J Schiller, Sascha A Tuchman, et al.
Pageof 2